Neuroimaging of narcolepsy

CNS and Neurological Disorders - Drug Targets

Volumn 8, Issue 4, 2009, Pages 254-263

  Dang Vu, Thien Thanh ^a,b   Desseilles, Martin ^a,b,c   Schwartz, Sophie ^c   Maquet, Pierre ^a,b  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b UNIVERSITY OF LIÈGE   (Belgium)

^c UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

Cataplexy; fMRI; Functional neuroimaging; Modafinil; Narcolepsy; PET; Sleep; SPECT

Indexed keywords

2 HYDROXY 3 IODO 6 METHOXY [(1 ETHYL 2 PYRROLIDINYL)METHYL]BENZAMIDE I 123; 2' METHOXYPHENYL (N 2' PYRIDINYL) 4 FLUOROBENZAMIDOETHYLPIPERAZINE F 18; 2BETA CARBOMETHOXY 3BETA (4 FLUOROPHENYL)TROPANE C 11; 3 (3 FLUOROPROPYL)SPIPERONE F 18; DEXAMPHETAMINE; FLUORODEOXYGLUCOSE F 18; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; MODAFINIL; N (3 IODOPROPEN 2 YL) 2BETA CARBOMETHOXY 3BETA (4 CHLOROPHENYL)TROPANE I 123; N METHYL 4 PIPERIDYL BENZILATE C 11; OREXIN; RACLOPRIDE C 11; RADIOISOTOPE; TECHNETIUM 99M; UNCLASSIFIED DRUG; BENZHYDRYL DERIVATIVE; CENTRAL STIMULANT AGENT;

BRAIN DYSFUNCTION; CATAPLEXY; HUMAN; HYPNAGOGIC HALLUCINATION; HYPOTHALAMUS; LIMBIC SYSTEM; NARCOLEPSY; NEUROIMAGING; NEUROTRANSMISSION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PARASOMNIA; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; REGULATORY MECHANISM; REVIEW; SINGLE DRUG DOSE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SLEEP WAKING CYCLE; SYMPTOM; BIOLOGICAL MODEL; BRAIN; BRAIN MAPPING; DIAGNOSTIC IMAGING; DRUG EFFECT; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; SCINTISCANNING;

BENZHYDRYL COMPOUNDS; BRAIN; BRAIN MAPPING; CENTRAL NERVOUS SYSTEM STIMULANTS; DIAGNOSTIC IMAGING; HUMANS; MAGNETIC RESONANCE IMAGING; MODELS, NEUROLOGICAL; NARCOLEPSY; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 70350441465     PISSN: 18715273     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152709788921708     Document Type: Review

References (57)

1. Maquet, P.; Dive, D.; Salmon, E.; Sadzot, B.; Franco, G.; Poirrier, R.; von Frenckell, R.; Franck, G. Cerebral glucose utilization during sleep-wake cycle in man determined by positron emission tomography and [18F]2-fluoro-2- deoxy-D-glucose method. Brain Res., 1990, 513, 136-143.
2. 15)O PET study. Brain, 1997, 120, 1173-1197.
3. Kajimura, N.; Uchiyama, M.; Takayama, Y.; Uchida, S.; Uema, T.; Kato, M.; Sekimoto, M.; Watanabe, T.; Nakajima, T.; Horikoshi, S.; Ogawa, K.; Nishikawa, M.; Hiroki, M.; Kudo, Y.; Matsuda, H.; Okawa, M.; Takahashi, K. Activity of midbrain reticular formation and neocortex during the progression of human non-rapid eye movement sleep. J. Neurosci., 1999, 19, 10065-10073.
4. Maquet, P.; Degueldre, C.; Delfiore, G.; Aerts, J.; Peters, J.M.; Luxen, A.; Franck, G. Functional neuroanatomy of human slow wave sleep. J. Neurosci., 1997, 17, 2807-2812.
5. Nofzinger, E.A.; Buysse, D.J.; Miewald, J.M.; Meltzer, C.C.; Price, J.C.; Sembrat, R.C.; Ombao, H.; Reynolds, C.F.; Monk, T.H.; Hall, M.; Kupfer, D.J.; Moore, R.Y. Human regional cerebral glucose metabolism during non-rapid eye movement sleep in relation to waking. Brain, 2002, 125, 1105-1115.
6. Kaufmann, C.; Wehrle, R.; Wetter, T.C.; Holsboer, F.; Auer, D.P.; Pollmacher, T.; Czisch, M. Brain activation and hypothalamic functional connectivity during human non-rapid eye movement sleep: an EEG/fMRI study. Brain, 2006, 129, 655-667.
7. Maquet, P.; Peters, J.; Aerts, J.; Delfiore, G.; Degueldre, C.; Luxen, A.; Franck, G. Functional neuroanatomy of human rapid-eye-movement sleep and dreaming. Nature, 1996, 383, 163-166.
8. Nofzinger, E.A.; Mintun, M.A.; Wiseman, M.; Kupfer, D.J.; Moore, R.Y. Forebrain activation in REM sleep: an FDG PET study. Brain Res., 1997, 770, 192-201.
9. Steriade, M.; McCarley, R.W. Brain Control of Wakefulness and Sleep; Springer: New York, 2005.
10. Schabus, M.; Dang-Vu, T.T.; Albouy, G.; Balteau, E.; Boly, M.; Carrier, J.; Darsaud, A.; Degueldre, C.; Desseilles, M.; Gais, S.; Phillips, C.; Rauchs, G.; Schnakers, C.; Sterpenich, V.; Vandewalle, G.; Luxen, A.; Maquet, P. Hemodynamic cerebral correlates of sleep spindles during human non-rapid eye movement sleep. Proc. Natl. Acad. Sci. USA, 2007, 104, 13164-13169.
11. Dang-Vu, T.T.; Schabus, M.; Desseilles, M.; Albouy, G.; Boly, M.; Darsaud, A.; Gais, S.; Rauchs, G.; Sterpenich, V.; Vandewalle, G.; Carrier, J.; Moonen, G.; Balteau, E.; Degueldre, C.; Luxen, A.; Phillips, C.; Maquet, P. Spontaneous neural activity during human slow wave sleep. Proc. Natl. Acad. Sci. USA, 2008, 105, 15160-15165.
12. Peigneux, P.; Laureys, S.; Fuchs, S.; Delbeuck, X.; Degueldre, C.; Aerts, J.; Delfiore, G.; Luxen, A.; Maquet, P. Generation of rapid eye movements during paradoxical sleep in humans. Neuroimage, 2001, 14, 701-708.
13. Wehrle, R.; Czisch, M.; Kaufmann, C.; Wetter, T.C.; Holsboer, F.; Auer, D.P.; Pollmächer, T. Rapid eye movement-related brain activation in human sleep: a functional magnetic resonance imaging study. Neuroreport, 2005, 16, 853-857.
14. Miyauchi, S.; Misaki, M.; Kan, S.; Fukunaga, T.; Koike, T. Human brain activity time-locked to rapid eye movements during REM sleep. Exp. Brain Res., 2009, 192, 657-667.
15. Dang-Vu, T.T.; Desseilles, M.; Petit, D.; Mazza, S.; Montplaisir, J.; Maquet, P. Neuroimaging in sleep medicine. Sleep Med., 2007, 8, 349-372.
16. Desseilles, M.; Dang-Vu, T.; Schabus, M.; Sterpenich, V.; Maquet, P.; Schwartz, S. Neuroimaging insights into the pathophysiology of sleep disorders. Sleep, 2008, 31, 777-794.
17. Drummond, S.P.; Smith, M.T.; Orff, H.J.; Chengazi, V.; Perlis, M.L. Functional imaging of the sleeping brain: review of findings and implications for the study of insomnia. Sleep Med. Rev., 2004, 8, 227-242.
18. Nofzinger, E.A. Neuroimaging and sleep medicine. Sleep Med. Rev., 2005, 9, 157-172.
19. Plazzi, G.; Montagna, P.; Provini, F.; Bizzi, A.; Cohen, M.; Lugaresi, E. Pontine lesions in idiopathic narcolepsy. Neurology, 1996, 46, 1250-1254.
20. Bassetti, C.; Aldrich, M.S.; Quint, D.J. MRI findings in narcolepsy. Sleep, 1997, 20, 630-631.
21. Frey, J.L.; Heiserman, J.E. Absence of pontine lesions in narcolepsy. Neurology, 1997, 48, 1097-1099.
22. Overeem, S.; Steens, S.C.; Good, C.D.; Ferrari, M.D.; Mignot, E.; Frackowiak, R.S.; van Buchem, M.A.; Lammers, G.J. Voxel-based morphometry in hypocretin-deficient narcolepsy. Sleep, 2003, 26, 44-46.
23. Kaufmann, C.; Schuld, A.; Pollmacher, T.; Auer, D.P. Reduced cortical gray matter in narcolepsy: preliminary findings with voxel-based morphometry. Neurology, 2002, 58, 1852-1855.
24. Brenneis, C.; Brandauer, E.; Frauscher, B.; Schocke, M.; Trieb, T.; Poewe, W.; Högl, B. Voxel-based morphometry in narcolepsy. Sleep Med., 2005, 6, 531-536.
25. Rieger, M.; Mayer, G.; Gauggel, S. Attention deficits in patients with narcolepsy. Sleep, 2003, 26, 36-43.
26. Draganski, B.; Geisler, P.; Hajak, G.; Schuierer, G.; Bogdahn, U.; Winkler, J.; May, A. Hypothalamic gray matter changes in narcoleptic patients. Nat. Med., 2002, 8, 1186-1188.
27. Buskova, J.; Vaneckova, M.; Sonka, K.; Seidl, Z.; Nevsimalova, S. Reduced hypothalamic gray matter in narcolepsy with cataplexy. Neuroendocrinol. Lett., 2006, 27, 769-772.
28. Lodi, R.; Tonon, C.; Vignatelli, L.; Iotti, S.; Montagna, P.; Barbiroli, B.; Plazzi, G. In vivo evidence of neuronal loss in the hypothalamus of narcoleptic patients. Neurology, 2004, 63, 1513-1515.
29. Ellis, C.M.; Simmons, A.; Lemmens, G.; Williams, S.C.; Parkes, J.D. Proton spectroscopy in the narcoleptic syndrome. Is there evidence of a brainstem lesion? Neurology, 1998, 50, S23-S26.
30. Kim, S.J.; Lyoo, I.K.; Lee, Y.S.; Sung, Y.H.; Kim, H.J.; Kim, J.H.; Jeong, D.U. Increased GABA levels in medial prefrontal cortex of young adults with narcolepsy. Sleep, 2008, 31, 342-347.
31. Yeon Joo, E.; Hong, S.B.; Tae, W.S.; Kim, J.H.; Han, S.J.; Cho, Y.W.; Yoon, C.H.; Lee, S.I.; Lee, M.H.; Lee, K.H.; Kim, M.H.; Kim, B.T.; Kim, L. Cerebral perfusion abnormality in narcolepsy with cataplexy. Neuroimage, 2005, 28, 410-416.
32. Joo, E.Y.; Tae, W.S.; Kim, J.H.; Kim, B.T.; Hong, S.B. Glucose hypometabolism of hypothalamus and thalamus in narcolepsy. Ann. Neurol., 2004, 56, 437-440.
33. Sudo, Y.; Suhara, T.; Honda, Y.; Nakajima, T.; Okubo, Y.; Suzuki, K.; Nakashima, Y.; Yoshikawa, K.; Okauchi, T.; Sasaki, Y.; Matsushita, M. Muscarinic cholinergic receptors in human narcolepsy: a PET study. Neurology, 1998, 51, 1297-1302.
34. 18)F]MPPF PET study in narcolepsy. Neuroimage, 2006, 30, 341-348.
35. Portas, C.M.; Bjorvatn, B.; Fagerland, S.; Gronli, J.; Mundal, V.; Sorensen, E.; Ursin, R. On-line detection of extracellular levels of serotonin in dorsal raphe nucleus and frontal cortex over the sleep/wake cycle in the freely moving rat. Neuroscience, 1998, 83, 807-814.
36. Eisensehr, I.; Linke, R.; Tatsch, K.; von Lindeiner, H.; Kharraz, B.; Gildehaus, F.J.; Eberle, R.; Pollmacher, T.; Schuld, A.; Noachtar, S. Alteration of the striatal dopaminergic system in human narcolepsy. Neurology, 2003, 60, 1817-1819.
37. 123I-IBZM. Acta Neurol. Scand., 1994, 90, 186-189.
38. 123I] IBZM SPET analysis of dopamine D2 receptor occupancy in narcoleptic patients in the course of treatment. Biol. Psychiatry, 1996, 39, 107-111.
39. 11C-raclopride. Neurology, 1994, 44, 2102-2104.
40. Rinne, J.O.; Hublin, C.; Partinen, M.; Ruottinen, H.; Ruotsalainen, U.; Nagren, K.; Lehikoinen, P.; Laihinen, A. Positron emission tomography study of human narcolepsy: no increase in striatal dopamine D2 receptors. Neurology, 1995, 45, 1735-1738.
41. MacFarlane, J.G.; List, S.J.; Moldofsky, H.; Firnau, G.; Chen, J.J.; Szechtman, H.; Garnett, S. Dopamine D2 receptors quantified in vivo in human narcolepsy. Biol. Psychiatry, 1997, 41, 305-310.
42. 11C]-CFT. Acta Neurol. Scand., 2004, 109, 52-55.
43. Meyer, J.S.; Sakai, F.; Karacan, I.; Derman, S.; Yamamoto, M. Sleep apnea, narcolepsy, and dreaming: regional cerebral hemodynamics. Ann. Neurol., 1980, 7, 479-485.
44. Asenbaum, S.; Zeithofer, J.; Saletu, B.; Frey, R.; Brucke, T.; Podreka, I.; Deecke, L. Technetium-99m-HMPAO SPECT imaging of cerebral blood flow during REM sleep in narcoleptics. J. Nucl. Med., 1995, 36, 1150-1155.
45. Dang-Vu, T.T.; Desseilles, M.; Laureys, S.; Degueldre, C.; Perrin, F.; Phillips, C.; Maquet, P.; Peigneux, P. Cerebral correlates of delta waves during non-REM sleep revisited. Neuroimage, 2005, 28, 14-21.
46. Chabas, D.; Habert, M.O.; Maksud, P.; Tourbah, A.; Minz, M.; Willer, J.C.; Arnulf, I. Functional imaging of cataplexy during status cataplecticus. Sleep, 2007, 30, 153-156.
47. Hong, S.B.; Tae, W.S.; Joo, E.Y. Cerebral perfusion changes during cataplexy in narcolepsy patients. Neurology, 2006, 66, 1747-1749.
48. Schwartz, S.; Maquet, P. Sleep imaging and the neuropsychological assessment of dreams. Trends Cogn. Sci., 2002, 6, 23-30.
49. Schwartz, S.; Ponz, A.; Poryazova, R.; Werth, E.; Boesiger, P.; Khatami, R.; Bassetti, C.L. Abnormal activity in hypothalamus and amygdala during humour processing in human narcolepsy with cataplexy. Brain, 2008, 131, 514-522.
50. Reiss, A.L.; Hoeft, F.; Tenforde, A.S.; Chen, W.; Mobbs, D.; Mignot, E.J. Anomalous hypothalamic responses to humor in cataplexy. PLoS ONE, 2008, 3(5), e2225.
51. Howard, R.J.; Ellis, C.; Bullmore, E.T.; Brammer, M.; Mellers, J.D.; Woodruff, P.W.; David, A.S.; Simmons, A.; Williams, S.C.; Parkes, J.D. Functional echoplanar brain imaging correlates of amphetamine administration to normal subjects and subjects with the narcoleptic syndrome. Magn. Reson. Imaging, 1996, 14, 1013-1016.
52. Joo, E.Y.; Tae, W.S.; Jung, K.Y.; Hong, S.B. Cerebral blood flow changes in man by wake-promoting drug, modafinil: a randomized double blind study. J. Sleep Res., 2008, 17, 82-88.
53. Thomas, R.J.; Kwong, K. Modafinil activates cortical and subcortical sites in the sleep-deprived state. Sleep, 2006, 29, 1471-1481.
54. Ellis, C.M.; Monk, C.; Simmons, A.; Lemmens, G.; Williams, S.C.; Brammer, M.; Bullmore, E.; Parkes, J.D. Functional magnetic resonance imaging neuroactivation studies in normal subjects and subjects with the narcoleptic syndrome. Actions of modafinil. J. Sleep Res., 1999, 8, 85-93.
55. Kim, Y.K.; Yoon, I.Y.; Shin, Y.K.; Cho, S.S.; Kim, S.E. Modafinil-induced hippocampal activation in narcolepsy. Neurosci. Lett., 2007, 422, 91-96.
56. Joo, E.Y.; Seo, D.W.; Tae, W.S.; Hong, S.B. Effect of modafinil on cerebral blood flow in narcolepsy patients. Sleep, 2008, 31, 868-873.
57. Maquet, P. Functional neuroimaging of normal human sleep by positron emission tomography. J. Sleep Res., 2000, 9, 207-231.